| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 16.03.2014 (3696
dage). |
Ingen historik.
| Branche | | Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000). |
| Sidst opdateret den 25.03.2014 og
angivet som gældende fra 16.03.2014 (3696
dage). |
Ingen historik.
| Revisionfravalgt | | false. |
| Sidst opdateret den 10.07.2015 og
angivet som gældende fra 10.07.2015 (3215
dage). |
| Historik | Start | Stop |
|---|
| false | 10.07.2015 | |
| true | 16.03.2014 | 09.07.2015 |
| Kontaktoplysninger | | info@injecto.eu. |
| Sidst opdateret den 12.11.2014 og
angivet som gældende fra 11.11.2014 (3456
dage). |
| Historik | Start | Stop |
|---|
| info@injecto.eu | 11.11.2014 | |
| mikkelhetting@youmail.dk | 16.03.2014 | 10.11.2014 |
| Telefonnummer | | 27851000. |
| Sidst opdateret den 12.11.2014 og
angivet som gældende fra 11.11.2014 (3456
dage). |
| Historik | Start | Stop |
|---|
| 27851000 | 11.11.2014 | |
| 61344719 | 16.03.2014 | 10.11.2014 |
| Navne | | Injecto Group A/S. |
| Sidst opdateret den 23.11.2019 og
angivet som gældende fra 22.11.2019 (1619
dage). |
| Historik | Start | Stop |
|---|
| Injecto Group A/S | 22.11.2019 | |
| Injecto A/S | 25.03.2015 | 21.11.2019 |
| INJECTO ApS | 17.09.2014 | 24.03.2015 |
| MEDIJECT ApS | 16.03.2014 | 16.09.2014 |
| Binavne | | MediJect A/S. |
| Sidst opdateret den 27.03.2015 og
angivet som gældende fra 27.03.2015 (3320
dage). |
| Historik | Start | Stop |
|---|
| MediJect A/S | 27.03.2015 | |
| MEDIJECT ApS | 16.03.2014 | 26.03.2015 |
| Tegningsregel | | Selskabet tegnes af den administrerende direktør og 2 bestyrelsesmedlemmer i forening, den samlede
bestyrelse eller af den administrerende direktør og bestyrelsesformanden i
forening. |
| Sidst opdateret den 07.02.2024 og
angivet som gældende fra 07.02.2024 (81
dage). |
| Fortolkning
(3 tegningsmuligheder)
| | direktøren + 2 bestyrelsesmedlemmer |
| bestyrelsen |
| direktøren + formanden |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af den administrerende direktør og 2 bestyrelsesmedlemmer i forening, den samlede
bestyrelse eller af den administrerende direktør og bestyrelsesformanden i
forening | 07.02.2024 | |
| Selskabet tegnes af den adm. direktør og 2 bestyrelsesmedlemmer i forening eller af den adm. direktør og bestyrelsesformanden i forening | 11.11.2014 | 06.02.2024 |
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Beskrivelse af revisor:State Authorised, Public Accountant
Grundlag for konklusion (revision):Basis for opinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the consolidated financial statements and the parent company financial statements" (hereinafter collectively referred to as "the financial statements") section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):OpinionWe have audited the consolidated financial statements and the parent company financial statements of Injecto Group A/S for the financial year 1 September 2022 – 31 August 2023, which comprise income statement, statement of comprehensive income, balance sheet, statement of changes in equity, cash flow statement and notes, including accounting policies, for the Group and the Parent Company. The consolidated financial statements and the parent company financial statements are prepared in accordance with IFRS Accounting Standards as adopted by the EU and additional requirements of the Danish Financial Statements Act. In our opinion, the consolidated financial statements and the parent company financial statements give a true and fair view of the financial position of the Group and the Parent Company at 31 August 2023 and of the results of the Group's and the Parent Company's operations and cash flows for the financial year 1 September 2022 – 31 August 2023 in accordance with International Financial Reporting Standards as adopted by the EU and additional requirements of the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's reviewManagement is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on our procedures, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Hjemmeside | | www.injecto.eu. |
| Sidst opdateret den 05.02.2018 og
angivet som gældende fra 05.02.2018 (2274
dage). |
Ingen historik.
LoginOpret gratis brugere-conomic integration